*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>The compound <strong>(2R,5S,13aR)-8-methoxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-1H-cyclopenta[a]phenanthrene-10-carboxamide</strong> is a specialized intermediate in the synthesis of potent corticosteroid analogs. Produced via stereoselective hydrogenation and amide coupling, its molecular formula is <strong>C25H25F3NO4</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing:</strong> Precursor for anti-inflammatory drug formulations.</li>
<li><strong>API Synthesis:</strong> Critical building block for developing novel glucocorticoids.</li>
<li><strong>Research & Development:</strong> Used in clinical trials for targeted metabolic disorder treatments.</li>
</ul>
<h3>Precautions</h3>
<ul>
<li><strong>Safety:</strong> Requires PPE handling to prevent skin irritation.</li>
<li><strong>Storage:</strong> Maintain at -20°C under inert atmosphere.</li>
<li><strong>Regulatory:</strong> Not approved for direct human consumption; strictly for industrial use.</li>
</ul>